ID   PLCH1_HUMAN             Reviewed;        1693 AA.
AC   Q4KWH8; Q29RV9; Q4KWH9; Q68CN0; Q86XK4; Q9H9U2; Q9UPT3;
DT   08-APR-2008, integrated into UniProtKB/Swiss-Prot.
DT   02-AUG-2005, sequence version 1.
DT   10-MAY-2017, entry version 122.
DE   RecName: Full=1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-1;
DE            EC=3.1.4.11;
DE   AltName: Full=Phosphoinositide phospholipase C-eta-1;
DE   AltName: Full=Phospholipase C-eta-1;
DE            Short=PLC-eta-1;
DE   AltName: Full=Phospholipase C-like protein 3;
DE            Short=PLC-L3;
GN   Name=PLCH1; Synonyms=KIAA1069, PLCL3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 3), FUNCTION, TISSUE
RP   SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=15702972; DOI=10.1042/BJ20041677;
RA   Hwang J.-I., Oh Y.-S., Shin K.-J., Kim H., Ryu S.H., Suh P.-G.;
RT   "Molecular cloning and characterization of a novel phospholipase C,
RT   PLC-eta.";
RL   Biochem. J. 389:181-186(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 926-1693 (ISOFORM 1).
RC   TISSUE=Eye, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 216-1693 (ISOFORM 3).
RC   TISSUE=Brain;
RX   PubMed=10470851; DOI=10.1093/dnares/6.3.197;
RA   Kikuno R., Nagase T., Ishikawa K., Hirosawa M., Miyajima N.,
RA   Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XIV.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 6:197-205(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 392-1034 (ISOFORM 4).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1470-1693 (ISOFORMS 1/2).
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
CC   -!- FUNCTION: The production of the second messenger molecules
CC       diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3) is
CC       mediated by calcium-activated phosphatidylinositol-specific
CC       phospholipase C enzymes. {ECO:0000269|PubMed:15702972}.
CC   -!- CATALYTIC ACTIVITY: 1-phosphatidyl-1D-myo-inositol 4,5-
CC       bisphosphate + H(2)O = 1D-myo-inositol 1,4,5-trisphosphate +
CC       diacylglycerol.
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:15702972}.
CC       Membrane {ECO:0000269|PubMed:15702972}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=PLC-eta-1;
CC         IsoId=Q4KWH8-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q4KWH8-2; Sequence=VSP_032901, VSP_032902;
CC         Note=No experimental confirmation available.;
CC       Name=3; Synonyms=PLC-eta-1a;
CC         IsoId=Q4KWH8-3; Sequence=VSP_032904, VSP_032905;
CC       Name=4;
CC         IsoId=Q4KWH8-4; Sequence=VSP_032902, VSP_032903, VSP_032906;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in brain and to a lower extent in
CC       lung. In brain, it is found in cerebrum, cerebellum and spinal
CC       cord. {ECO:0000269|PubMed:15702972}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB14129.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY691170; AAW22607.1; -; mRNA.
DR   EMBL; AY691171; AAW22608.1; -; mRNA.
DR   EMBL; BC043248; AAH43248.2; -; mRNA.
DR   EMBL; BC113950; AAI13951.1; -; mRNA.
DR   EMBL; AB028992; BAA83021.1; -; mRNA.
DR   EMBL; AK022610; BAB14129.1; ALT_INIT; mRNA.
DR   EMBL; CR749869; CAH18710.1; -; mRNA.
DR   CCDS; CCDS46939.1; -. [Q4KWH8-1]
DR   CCDS; CCDS46940.1; -. [Q4KWH8-3]
DR   RefSeq; NP_001124432.1; NM_001130960.1. [Q4KWH8-1]
DR   RefSeq; NP_001124433.1; NM_001130961.1. [Q4KWH8-3]
DR   RefSeq; NP_055811.1; NM_014996.2. [Q4KWH8-2]
DR   RefSeq; XP_016861418.1; XM_017005929.1. [Q4KWH8-3]
DR   UniGene; Hs.567423; -.
DR   ProteinModelPortal; Q4KWH8; -.
DR   SMR; Q4KWH8; -.
DR   BioGrid; 116651; 6.
DR   IntAct; Q4KWH8; 4.
DR   STRING; 9606.ENSP00000345988; -.
DR   SwissLipids; SLP:000000940; -.
DR   iPTMnet; Q4KWH8; -.
DR   PhosphoSitePlus; Q4KWH8; -.
DR   BioMuta; PLCH1; -.
DR   DMDM; 121947010; -.
DR   EPD; Q4KWH8; -.
DR   MaxQB; Q4KWH8; -.
DR   PaxDb; Q4KWH8; -.
DR   PeptideAtlas; Q4KWH8; -.
DR   PRIDE; Q4KWH8; -.
DR   Ensembl; ENST00000334686; ENSP00000335469; ENSG00000114805. [Q4KWH8-2]
DR   Ensembl; ENST00000340059; ENSP00000345988; ENSG00000114805. [Q4KWH8-1]
DR   Ensembl; ENST00000447496; ENSP00000402759; ENSG00000114805. [Q4KWH8-3]
DR   Ensembl; ENST00000460012; ENSP00000417502; ENSG00000114805. [Q4KWH8-2]
DR   Ensembl; ENST00000494598; ENSP00000419100; ENSG00000114805. [Q4KWH8-4]
DR   GeneID; 23007; -.
DR   KEGG; hsa:23007; -.
DR   UCSC; uc062pff.1; human. [Q4KWH8-1]
DR   CTD; 23007; -.
DR   DisGeNET; 23007; -.
DR   GeneCards; PLCH1; -.
DR   H-InvDB; HIX0119148; -.
DR   HGNC; HGNC:29185; PLCH1.
DR   HPA; HPA036176; -.
DR   HPA; HPA057978; -.
DR   MIM; 612835; gene.
DR   neXtProt; NX_Q4KWH8; -.
DR   OpenTargets; ENSG00000114805; -.
DR   PharmGKB; PA128394595; -.
DR   eggNOG; KOG0169; Eukaryota.
DR   eggNOG; ENOG410XPSW; LUCA.
DR   GeneTree; ENSGT00760000118936; -.
DR   HOVERGEN; HBG095591; -.
DR   InParanoid; Q4KWH8; -.
DR   KO; K19006; -.
DR   OMA; NGYCKET; -.
DR   OrthoDB; EOG091G02KH; -.
DR   PhylomeDB; Q4KWH8; -.
DR   TreeFam; TF313216; -.
DR   BRENDA; 3.1.4.11; 2681.
DR   Reactome; R-HSA-1855204; Synthesis of IP3 and IP4 in the cytosol.
DR   ChiTaRS; PLCH1; human.
DR   GenomeRNAi; 23007; -.
DR   PRO; PR:Q4KWH8; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000114805; -.
DR   CleanEx; HS_PLCH1; -.
DR   Genevisible; Q4KWH8; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:MGI.
DR   GO; GO:0005829; C:cytosol; IEA:Ensembl.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0050429; F:calcium-dependent phospholipase C activity; IDA:MGI.
DR   GO; GO:0004435; F:phosphatidylinositol phospholipase C activity; TAS:Reactome.
DR   GO; GO:0004871; F:signal transducer activity; IEA:UniProtKB-KW.
DR   GO; GO:0043647; P:inositol phosphate metabolic process; TAS:Reactome.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0048015; P:phosphatidylinositol-mediated signaling; IDA:MGI.
DR   CDD; cd00051; EFh; 1.
DR   Gene3D; 2.30.29.30; -; 1.
DR   Gene3D; 2.60.40.150; -; 1.
DR   Gene3D; 3.20.20.190; -; 1.
DR   InterPro; IPR000008; C2_dom.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR011993; PH_dom-like.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR001192; PI-PLC_fam.
DR   InterPro; IPR028392; PLC-eta1.
DR   InterPro; IPR017946; PLC-like_Pdiesterase_TIM-brl.
DR   InterPro; IPR015359; PLC_EF-hand-like.
DR   InterPro; IPR000909; PLipase_C_PInositol-sp_X_dom.
DR   InterPro; IPR001711; PLipase_C_Pinositol-sp_Y.
DR   PANTHER; PTHR10336; PTHR10336; 1.
DR   PANTHER; PTHR10336:SF115; PTHR10336:SF115; 1.
DR   Pfam; PF00168; C2; 1.
DR   Pfam; PF09279; EF-hand_like; 1.
DR   Pfam; PF00388; PI-PLC-X; 1.
DR   Pfam; PF00387; PI-PLC-Y; 1.
DR   PRINTS; PR00390; PHPHLIPASEC.
DR   SMART; SM00239; C2; 1.
DR   SMART; SM00054; EFh; 2.
DR   SMART; SM00233; PH; 1.
DR   SMART; SM00148; PLCXc; 1.
DR   SMART; SM00149; PLCYc; 1.
DR   SUPFAM; SSF47473; SSF47473; 1.
DR   SUPFAM; SSF49562; SSF49562; 1.
DR   SUPFAM; SSF50729; SSF50729; 1.
DR   SUPFAM; SSF51695; SSF51695; 2.
DR   PROSITE; PS50004; C2; 1.
DR   PROSITE; PS00018; EF_HAND_1; 1.
DR   PROSITE; PS50222; EF_HAND_2; 3.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
DR   PROSITE; PS50007; PIPLC_X_DOMAIN; 1.
DR   PROSITE; PS50008; PIPLC_Y_DOMAIN; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Complete proteome; Cytoplasm;
KW   Hydrolase; Lipid degradation; Lipid metabolism; Membrane;
KW   Metal-binding; Reference proteome; Repeat; Transducer.
FT   CHAIN         1   1693       1-phosphatidylinositol 4,5-bisphosphate
FT                                phosphodiesterase eta-1.
FT                                /FTId=PRO_0000329007.
FT   DOMAIN       20    128       PH. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00145}.
FT   DOMAIN      142    177       EF-hand 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   DOMAIN      178    214       EF-hand 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   DOMAIN      299    444       PI-PLC X-box. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00270}.
FT   DOMAIN      601    714       PI-PLC Y-box. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00271}.
FT   DOMAIN      719    826       C2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00041}.
FT   CA_BIND     155    166       {ECO:0000255|PROSITE-ProRule:PRU00448}.
FT   COMPBIAS   1026   1030       Poly-Ser.
FT   ACT_SITE    314    314       {ECO:0000255|PROSITE-ProRule:PRU00270}.
FT   ACT_SITE    358    358       {ECO:0000255|PROSITE-ProRule:PRU00270}.
FT   METAL       315    315       Calcium 1; catalytic. {ECO:0000250}.
FT   METAL       344    344       Calcium 1; catalytic. {ECO:0000250}.
FT   METAL       346    346       Calcium 1; catalytic. {ECO:0000250}.
FT   METAL       393    393       Calcium 1; catalytic. {ECO:0000250}.
FT   METAL       758    758       Calcium 2; via carbonyl oxygen.
FT                                {ECO:0000250}.
FT   METAL       760    760       Calcium 2. {ECO:0000250}.
FT   METAL       784    784       Calcium 2. {ECO:0000250}.
FT   METAL       813    813       Calcium 3. {ECO:0000250}.
FT   METAL       814    814       Calcium 3; via carbonyl oxygen.
FT                                {ECO:0000250}.
FT   METAL       815    815       Calcium 3. {ECO:0000250}.
FT   BINDING     442    442       Substrate. {ECO:0000250}.
FT   BINDING     444    444       Substrate. {ECO:0000250}.
FT   BINDING     627    627       Substrate. {ECO:0000250}.
FT   BINDING     654    654       Substrate. {ECO:0000250}.
FT   VAR_SEQ       1     18       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_032901.
FT   VAR_SEQ     862    881       Missing (in isoform 2 and isoform 4).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_032902.
FT   VAR_SEQ    1000   1034       AEDKDGRRKGKASIKDPHFLNFNKKLSSSSSALLH -> DS
FT                                SFCRPTEQAKAEMCKVPFPRQLECVMKMEISET (in
FT                                isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_032903.
FT   VAR_SEQ    1000   1002       AED -> VQI (in isoform 3).
FT                                {ECO:0000303|PubMed:10470851,
FT                                ECO:0000303|PubMed:15702972}.
FT                                /FTId=VSP_032904.
FT   VAR_SEQ    1003   1693       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:10470851,
FT                                ECO:0000303|PubMed:15702972}.
FT                                /FTId=VSP_032905.
FT   VAR_SEQ    1035   1693       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_032906.
SQ   SEQUENCE   1693 AA;  189223 MW;  00F2ADD21C4D14E6 CRC64;
     MADLEVYKNL SPEKVERCMS VMQSGTQMIK LKRGTKGLVR LFYLDEHRTR LRWRPSRKSE
     KAKILIDSIY KVTEGRQSEI FHRQAEGNFD PSCCFTIYHG NHMESLDLIT SNPEEARTWI
     TGLKYLMAGI SDEDSLAKRQ RTHDQWVKQT FEEADKNGDG LLNIEEIHQL MHKLNVNLPR
     RKVRQMFQEA DTDENQGTLT FEEFCVFYKM MSLRRDLYLL LLSYSDKKDH LTVEELAQFL
     KVEQKMNNVT TDYCLDIIKK FEVSEENKVK NVLGIEGFTN FMRSPACDIF NPLHHEVYQD
     MDQPLCNYYI ASSHNTYLTG DQLLSQSKVD MYARVLQEGC RCVEVDCWDG PDGEPVVHHG
     YTLTSKILFR DVVETINKHA FVKNEFPVIL SIENHCSIQQ QRKIAQYLKG IFGDKLDLSS
     VDTGECKQLP SPQSLKGKIL VKGKKLPYHL GDDAEEGEVS DEDSADEIED ECKFKLHYSN
     GTTEHQVESF IRKKLESLLK ESQIRDKEDP DSFTVRALLK ATHEGLNAHL KQSPDVKESG
     KKSHGRSLMT NFGKHKKTTK SRSKSYSTDD EEDTQQSTGK EGGQLYRLGR RRKTMKLCRE
     LSDLVVYTNS VAAQDIVDDG TTGNVLSFSE TRAHQVVQQK SEQFMIYNQK QLTRIYPSAY
     RIDSSNFNPL PYWNAGCQLV ALNYQSEGRM MQLNRAKFKA NGNCGYVLKP QQMCKGTFNP
     FSGDPLPANP KKQLILKVIS GQQLPKPPDS MFGDRGEIID PFVEVEIIGL PVDCCKDQTR
     VVDDNGFNPV WEETLTFTVH MPEIALVRFL VWDHDPIGRD FVGQRTVTFS SLVPGYRHVY
     LEGLTEASIF VHITINEIYG KWSPLILNPS YTILHFLGAT KNRQLQGLKG LFNKNPRHSS
     SENNSHYVRK RSIGDRILRR TASAPAKGRK KSKMGFQEMV EIKDSVSEAT RDQDGVLRRT
     TRSLQARPVS MPVDRNLLGA LSLPVSETAK DIEGKENSLA EDKDGRRKGK ASIKDPHFLN
     FNKKLSSSSS ALLHKDTSQG DTIVSTAHMS VTGEQLGMSS PRGGRTTSNA TSNCQENPCP
     SKSLSPKQHL APDPVVNPTQ DLHGVKIKEK GNPEDFVEGK SILSGSVLSH SNLEIKNLEG
     NRGKGRAATS FSLSDVSMLC SDIPDLHSTA ILQESVISHL IDNVTLTNEN EPGSSISALI
     GQFDETNNQA LTVVSHLHNT SVMSGHCPLP SLGLKMPIKH GFCKGKSKSS FLCSSPELIA
     LSSSETTKHA TNTVYETTCT PISKTKPDDD LSSKAKTAAL ESNLPGSPNT SRGWLPKSPT
     KGEDWETLKS CSPASSPDLT LEDVIADPTL CFNSGESSLV EIDGESENLS LTTCEYRREG
     TSQLASPLKL KYNQGVVEHF QRGLRNGYCK ETLRPSVPEI FNNIQDVKTQ SISYLAYQGA
     GFVHNHFSDS DAKMFQTCVP QQSSAQDMHV PVPKQLAHLP LPALKLPSPC KSKSLGDLTS
     EDIACNFESK YQCISKSFVT TGIRDKKGVT VKTKSLEPID ALTEQLRKLV SFDQEDNCQV
     LYSKQDANQL PRALVRKLSS RSQSRVRNIA SRAKEKQEAN KQKVPNPSNG AGVVLRNKPS
     APTPAVNRHS TGSYIAGYLK NTKGGGLEGR GIPEGACTAL HYGHVDQFCS DNSVLQTEPS
     SDDKPEIYFL LRL
//
